Cargando…

The Effect of Patient Factors and Cotreatments on the Magnitude of Potassium Lowering with Insulin–Glucose Treatment in Patients with Hyperkalemia

The management of hyperkalemia with insulin–glucose/dextrose treatment (IDT) may be influenced by patient factors and cotreatments. We aimed to determine the magnitude of potassium lowering by IDT while considering patient factors and cotreatments. We observed the change in serum potassium in 410 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Andy K. H., Crnobrnja, Ljiljana, Metlapalli, Manogna, Govinna, Mauli, Jiang, Cathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620900/ https://www.ncbi.nlm.nih.gov/pubmed/36417187 http://dx.doi.org/10.3390/epidemiologia2010003

Ejemplares similares

The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
por: Crnobrnja, Ljiljana, et al.
Publicado: (2020)

Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis
por: Lim, Andy K H, et al.
Publicado: (2021)

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)

Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020)

Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function
por: Coca, Armando, et al.
Publicado: (2017)

Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study
por: Yao, Lan, et al.
Publicado: (2022)

Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia
por: Li, Lingyun, et al.
Publicado: (2016)

High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
por: Kim, Daejin, et al.
Publicado: (2019)

Piecing Together the Potassium Puzzle: The Weak Association Between Dietary Potassium and Hyperkalemia
por: Joshi, Shivam, et al.
Publicado: (2023)

Impact of Plasma Potassium Normalization on Short‐Term Mortality in Patients With Hypertension and Hyperkalemia
por: Krogager, Maria Lukács, et al.
Publicado: (2020)

Low dialysis potassium bath is associated with lower mortality in end-stage renal disease patients admitted to hospital with severe hyperkalemia
por: Singh, Tripti, et al.
Publicado: (2020)

The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?
por: Batlle, Daniel, et al.
Publicado: (2015)

Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score)
por: Kijprasert, Weerapriya, et al.
Publicado: (2022)

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Hyperkalemia caused by rapid red cell transfusion and the potassium absorption filter
por: Imashuku, Yasuhiko, et al.
Publicado: (2017)

Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia
por: Huang, Chien-Wei, et al.
Publicado: (2015)

Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
por: Apel, Jill, et al.
Publicado: (2014)

Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin
por: Ozsurekci, Yasemin, et al.
Publicado: (2014)

Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives
por: Zappia, Carlos D., et al.
Publicado: (2019)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
por: Khanagavi, Jagadish, et al.
Publicado: (2014)

Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes
por: Alrashidi, Tahani Nasser, et al.
Publicado: (2020)

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients — A population-based cohort study
por: Adelborg, Kasper, et al.
Publicado: (2019)

A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
por: Cañas, Alejandro E., et al.
Publicado: (2023)

Insulin for the treatment of hyperkalemia: a double-edged sword?
por: Li, Tingting, et al.
Publicado: (2014)

Music Therapy and Nursing Cotreatment in Integrative Hospice and Palliative Care
por: Potvin, Noah, et al.
Publicado: (2021)

Course of Hyperkalemia in Patients on Hemodialysis
por: Spinowitz, Bruce, et al.
Publicado: (2022)

Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis
por: Montagnani, Andrea, et al.
Publicado: (2021)

Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis
por: Zhang, Yaru, et al.
Publicado: (2021)

Biological lignocellulose solubilization: comparative evaluation of biocatalysts and enhancement via cotreatment
por: Paye, Julie M. D., et al.
Publicado: (2016)

Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
por: Rabie, Helena, et al.
Publicado: (2020)

Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro
por: Feng, Wenli, et al.
Publicado: (2021)

Life threatening hyperkalemia treated with prolonged continuous insulin infusion
por: Awlad Thani, Saif, et al.
Publicado: (2019)

Comparison of IV Insulin Dosing Strategies for Hyperkalemia in the Emergency Department
por: Moussavi, Kayvan, et al.
Publicado: (2020)

Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders
por: Hida, Yuki, et al.
Publicado: (2023)

Management of hyperkalemia in the acutely ill patient
por: Dépret, François, et al.
Publicado: (2019)

Current Management of Hyperkalemia in Patients on Dialysis
por: Bansal, Shweta, et al.
Publicado: (2020)

Hyperkalemia in chronic peritoneal dialysis patients
por: Elliott, Andrew B., et al.
Publicado: (2022)

Sodium–calcium exchanger 1 is the key molecule for urinary potassium excretion against acute hyperkalemia
por: Shoda, Wakana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgmj7r690g6sd871atslaaiuqt